Mary J Laughlin

Title: Mary J Laughlin: Innovator in Lymphocyte Regulation and Ischemic Tissue Treatment

Introduction

Mary J Laughlin is a prominent inventor based in Shaker Heights, OH (US). She has made significant contributions to the field of medical science, particularly in the regulation of lymphocyte activity and the treatment of ischemic tissues. With a total of 2 patents, her work has the potential to impact therapeutic approaches in immunology and cardiology.

Latest Patents

Mary J Laughlin's latest patents include innovative methods that address critical health issues. One of her patents is titled "Method of regulating NFATc2 activity in lymphocytes." This method involves administering an NFATc2 mRNA antagonist to decrease NFATc2 activity in lymphocytes, which could have implications for various immune responses. Another significant patent is "Cell-based therapies for ischemia," which provides methods for treating ischemic tissues and increasing blood flow to areas in need, such as ischemic myocardium. These inventions highlight her commitment to advancing medical treatments.

Career Highlights

Mary J Laughlin is affiliated with Case Western Reserve University, where she continues her research and development efforts. Her work is characterized by a focus on innovative solutions to complex medical challenges.

Collaborations

Throughout her career, Mary has collaborated with notable colleagues, including Stephen E Haynesworth and Vincent Pompili. These partnerships have likely contributed to the depth and breadth of her research.

Conclusion

Mary J Laughlin stands out as an influential inventor whose work in lymphocyte regulation and ischemic tissue treatment showcases her dedication to improving health outcomes. Her patents reflect a commitment to innovation in the medical field.